COVID-19 MMR Vaccine Research

Substantial evidence indicates that the MMR II vaccine (known as MMRVaxPro in Europe) by Merck & Co. may inhibit development of SARS-CoV-2 infection or reduce COVID-19 severity. Our answers below are based upon early research, but nothing presented here should be relied upon to make medical decisions without consulting a physician or other qualified health professional.

Frequently Asked Questions

World Organization is a 501c3 public charity. World.Org and World Organization are registered trademarks of World Organization. Copyright © 2020 World Organization. All rights reserved.